Despite currently available treatments, risk of death and hospitalizations in patients with
heart failure with reduced ejection fraction (HFrEF) remains high. The pathophysiology of …

Heart failure (HF) is associated with a high morbidity and mortality burden. In light of more
recent evidence, SGLT2 inhibitors are currently recommended as first-line therapy in …

Background To evaluate the effectiveness of a cardiovascular polypill including aspirin,
ramipril and atorvastatin (CNIC-Polypill), on the incidence of recurrent major cardiovascular …

Objective: To estimate the prevalence, incidence, and describe the characteristics and
management of patients with heart failure with preserved (HFpEF), mildly reduced …

Objectives To describe the epidemiology, clinical profile, treatments, and to determine
cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic …

Aims To describe healthcare resource utilization (HCRU) of patients with heart failure with
preserved (HFpEF), mildly reduced (HFmrEF), and reduced ejection fraction (HFrEF) in …

Aims To examine the accuracy of diagnostic responses and types of information provided on
online health forums. Design Qualitative descriptive study. Methods This paper reports the …

Background Data about the impact of chronic kidney disease (CKD) on health care costs in
Spain are scarce This study was aimed to evaluate cumulative costs and healthcare …

Purpose This research examined the cost-effectiveness of adding empagliflozin to standard
of care (SoC) compared with SoC alone for treatment of heart failure with reduced ejection …

Background Moderate–severe atopic dermatitis (AD) has a significant impact on patients'
lives, with many requiring systemic treatment to manage symptoms (eg, pruritus). Several …